San Diego: A New Tack on Insulin-Based Therapies?
Shoring up insulin responses is a tried-and-true strategy for helping people manage type 2 diabetes (T2D), but could it also prevent or delay Alzheimer’s disease?...
1380 RESULTS
Sort By:
Shoring up insulin responses is a tried-and-true strategy for helping people manage type 2 diabetes (T2D), but could it also prevent or delay Alzheimer’s disease?...
Move over, mice; there are now one, and possibly two, models for amyotrophic lateral sclerosis in man’s best friend...
What causes Aβ to go rogue in Alzheimer’s disease?...
If posters at the Society for Neuroscience (SfN) meeting and a recent publication are any indication, the field is poised to discover a wealth of clues to TDP-43 function...
Mirroring a trend in amyloid-β research, work on the tau protein seems to be moving from tangles toward that infamous “O” word—oligomers...
Autosomal-dominant Alzheimer's and Huntington's disease family representatives spoke or showed videos about treatment trials...
Eight EMA officials and nine FDA officials took part in a discussion about preclinical trials in autosomal-dominant AD...
Part 2 of Alzforum’s coverage continues with what scientists from inside and outside DIAN said about the prospect of such pre-symptomatic trials...
The charge of this meeting was to begin a dialogue toward the shared goal of offering therapeutic treatment and prevention trials to families with autosomal-dominant AD...
A compound that partially activates α7 nicotinic acetylcholine receptors has shown promise at surprisingly low doses in early AD clinical trials...
Many scientists said the progress in identifying the basic biology behind FTDs may soon translate into new therapeutic targets...
Recent discoveries of the molecular underpinnings of nearly all frontotemporal dementias have nudged open a door for researchers to begin to unravel disease pathways...
Frontotemporal dementias pose a challenge for diagnosis because numerous overlapping clinical syndromes are associated with the disease...
The study of FTDs seems to have entered a season of growth...
Cancer and neurodegenerative diseases—what do they have in common, apart from the distress they cause to sufferers and their families?...